Atorvastatin Calcium
USP/1044516 - United States Pharmacopeia (USP) Reference Standard
Synonym: Atorvastatin hemicalcium salt sesquihydrate
CAS Number: 344423-98-9
Empirical Formula (Hill Notation): C66H68CaF2N4O10 · 3H2O
Molecular Weight: 1209.39
Linear Formula: C66H68CaF2N4O10 · 3H2O
Product Type: Chemical
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/2C33H35FN2O5.Ca.3H2O/c |
InChI key | SHZPNDRIDUBNMH-NIJVSVLQSA |
manufacturer/tradename | USP |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | It was used as standard in the method development and validation for simultaneous determination of Atorvastatin calcium and Ezetimibe in tablets using UV spectrophotometric, HPLC and HPTLC methods. |
General description: | Atorvastatin Calcium is a synthetic selective inhibitor of HMG-CoA reductase. It is insoluble in aqueous solution with pH below 4 and is freely soluble in methanol. This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Other Notes: | USP issued SDS can be found here . |
Symbol | GHS08 |
Signal word | Danger |
Hazard statements | H351 - H360D |
Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |